PD-L1 expression in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.

被引：0
|
作者：
Mamesaya, Nobuaki
Kenmotsu, Hirotsugu
Miyawaki, Eriko
Kotake, Mie
Kawamura, Takahisa
Kobayashi, Haruki
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20530
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evaluation of the prognostic marker of PD-L1 expression after combined radiochemotherapy in patients with non-small cell lung cancer (NSCLC) stage III
    Wagner, Jan
    Roeper, Julia
    Willborn, Kay
    Griesinger, Frank
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 159 - 159
  • [42] Durvalumab outcomes for patients with PD-L1 positive and negative stage III unresectable non-small cell lung cancer treated at veterans health administration facilities
    Burton, Elizabeth M.
    Moore, Amanda
    Nooruddin, Zohra
    Cotarla, Ion
    Simmons, Daniel
    Davis, Laura
    Reveles, Kelly R.
    Datta, Paromita
    Souza, Gabriel Roman
    Irabor, Omoruyi Credit
    Franklin, Kathleen
    Jones, Xavier
    Frei, Christopher R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
    Kerr, Keith M.
    Nicolson, Marianne C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254
  • [44] Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
    Harada, Hideyuki
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    Endo, Masahiro
    Murakami, Haruyasu
    Tsuya, Asuka
    Nakamura, Yukiko
    Ono, Akira
    Igawa, Satoshi
    Shukuya, Takehito
    Tamiya, Akihiro
    Nishimura, Tetsuo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (06) : 507 - 512
  • [45] Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer
    Tan, EH
    Wee, J
    Ang, PT
    Fong, KW
    Leong, SS
    Khoo, KS
    Tan, T
    Lee, KS
    Eng, P
    Hsu, A
    Tan, YK
    Chua, EJ
    Ong, YY
    ACTA ONCOLOGICA, 1999, 38 (08) : 1005 - 1009
  • [46] Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
    Hideyuki Harada
    Nobuyuki Yamamoto
    Toshiaki Takahashi
    Masahiro Endo
    Haruyasu Murakami
    Asuka Tsuya
    Yukiko Nakamura
    Akira Ono
    Satoshi Igawa
    Takehito Shukuya
    Akihiro Tamiya
    Tetsuo Nishimura
    International Journal of Clinical Oncology, 2009, 14 : 507 - 512
  • [47] Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients
    Nhung Pham
    Quyet Do
    Thang Ta
    Dung Nguyen
    Dai Do
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [48] PET for Prognostic Assessment in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Yilmaz, Ufuk
    Asuk, Zehra
    Koparal, Hakan
    Ozbilek, Engin
    Korkmaz, Esra
    Yalcin, Burcu
    Yilmaz, Hasan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S690 - S690
  • [49] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
    Price, Katharine A. R.
    Azzoli, Christopher G.
    Gaspar, Laurie E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209
  • [50] The Value of PD-L1 in Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Receiving Immunotherapy
    Xu, Y.
    Zhu, L.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S615 - S615
12345